Perioperative use of levosimendan: best practice in operative settings

J Cardiothorac Vasc Anesth. 2013 Apr;27(2):361-6. doi: 10.1053/j.jvca.2012.04.007. Epub 2012 May 30.

Authors

Wolfgang Toller¹, Lars Algotsson, Fabio Guarracino, Christoph Hörmann, Johann Knotzer, Andreas Lehmann, Angela Rajek, Markku Salmenperä, Uwe Schirmer, Luigi Tritapepe, Florian Weis, Giovanni Landoni

Affiliation

¹ Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Graz, Austria.

PMID: 22658687
DOI: 10.1053/j.jvca.2012.04.007

No abstract available

Publication types

Review

MeSH terms

Cardiac Output, Low / physiopathology
Cardiac Output, Low / therapy
Cardiac Surgical Procedures / methods*
Cardiotonic Agents / administration & dosage
Cardiotonic Agents / adverse effects
Cardiotonic Agents / therapeutic use*
Critical Illness
Humans
Hydrazones / administration & dosage
Hydrazones / adverse effects
Hydrazones / therapeutic use*
Perioperative Care
Pyridazines / administration & dosage
Pyridazines / adverse effects
Pyridazines / therapeutic use*
Randomized Controlled Trials as Topic
Simendan
Surgical Procedures, Operative

Substances

Cardiotonic Agents
Hydrazones
Pyridazines
Simendan